Page 2 - Endocr Pract News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Endocr pract. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Endocr Pract Today - Breaking & Trending Today

Lilly's Mounjaro leads to 16% weight loss for obese diabetics in trial

A large trial showed that a high dose of Eli Lilly and Co's Mounjaro helped people with type 2 diabetes who were also obese or overweight to lose nearly 16% of their body weight, or over 34 pounds (15kg) on average, the company said on Thursday. ....

Akash Tewari , Eli Lilly , Jeff Emmick , Thomson Reuters Trust Principles , Novo Nordisk Novob Co Ozempic , Co Llyn Mounjaro , Drug Administration , Novo Nordisk , Thomson Reuters Trust , Rhpi Drug Device Trials ,

Eli Lilly raises annual profit forecast on strength of diabetes drug

Eli Lilly and Co on Thursday raised its annual revenue and profit forecasts after topping first-quarter sales estimates on demand for its closely watched diabetes drug Mounjaro, ahead of a decision on its use as a treatment for obesity. ....

Eli Lilly , Bhanvi Satija , Drug Administration , Thomson Reuters Trust Principles , Thomson Reuters Trust , Rhpi Commercial Strategy , Rsbi Regulatory Oversight , Rhpi Drug Device Trials , Rhpi Regulatory ,

Novartis lifts full-year earnings outlook

Novartis on Tuesday raised its full-year earnings outlook after cutting costs, a breast cancer drug trial success and progress in boosting output of a radiotherapy drug against prostate cancer. ....

Ludwig Burger , Thomson Reuters Trust Principles , Thomson Reuters Trust , Rsbi Regulatory Oversight , Rhpi Commercial Strategy , Rhpi Regulatory ,

Exclusive: WHO to consider adding obesity drugs to 'essential' medicines list

Drugs that combat obesity could for the first time be included on the World Health Organization's "essential medicines list," used to guide government purchasing decisions in low- and middle-income countries, the U.N. agency told Reuters. ....

City Of , United Kingdom , United States , San Francisco , Sanjana Garimella , Zulfiqar Bhutta , Jennifer Rigby , Eli Lilly , Michele Gershberg , Sandeep Kishore , Thomson Reuters Trust Principles , Yale New Haven Health , Novo Nordisk Novob , University Of Toronto , Novo Nordisk , University Of California , World Health Organization , Thomson Reuters Trust , Rhpi Government Health Policy , Rhpi Public Health , Ef Business Future Of Health ,

Novartis says Kisqali breast cancer drug cuts risk of recurrence

Novartis's Kisqali breast cancer drug cut the risk of recurrence in women who were diagnosed at an early stage of the disease in a pivotal trial, providing a confidence boost for the drugmaker's growth prospects. ....

Ludwig Burger , Friederike Heine , Novartis Novns Kisqali , Thomson Reuters Trust Principles , Eli Lilly , Thomson Reuters Trust , Rsbi Regulatory Oversight , Rhpi Regulatory ,